Case of secondary deep venous disease. by Kistner, R L
3. The significant recoil after simple dilatation warrants a stent
insertion in all cases following venoplasty.
4. Stents should be inserted well into the IVC to prevent recurrence
of central stenosis.
5. The definite objective preoperative test to use for selection for this
procedure needs to be defined.
CASE OF SECONDARY DEEP VENOUS
DISEASE
Robert L Kistner, MD
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This 47-year old healthy male was referred with a 4-year history of
chronic venous ulceration of the right lower extremity due to
post-thrombotic disease of the femoral-popliteal-tibial veins.
The problem began 4 years ago with the spontaneous onset of
itching, discoloration, and a small sore on the posterior aspect of the
calf. Swelling and chronic aching with dependency were progres
sive, and the ulcer grew to a large, encircling lesion of the entire
circumference of the calf. Treatment by a series of 8 physicians
entailed many medications during this time, but elastic support was
not prescribed. No objective tests were done. During this time the
problem was progressive.
A clinically apparent DVT of the SFV was diagnosed one year ago
and treated with heparmn-coumadin. Workup for a hypercoagulable
state was negative.
3 months prior to this referral, he consulted a new physician who
diagnosed severe deep venous reflux and prescribed elevation of the
leg, pneumatic compression and pumping of the leg, and limitation
of activity. His ulcer closed over the next three months.
The dominant symptoms were aching and swelling of the leg, and
venous claudication with walking. The need to pump his leg inter
fered with his occupation as a traveling sales person. He had to stop
his hunting activities. The problem was that the treatment prescrip
tion to control the ulceration required a life-style change that was
incompatible with his desired way of life, and with his occupation.
P.E.: Healthy, strong 47-year old male. 5’ 10” tall, 230 lbs. Normal
physical examination including arterial pulses, except for venous
findings in RLE: Right calf 1 larger than left; large discoloration
encircling the leg, 6” in length on post-lat and 2” on medial sides; no
induration of skin, good turgor. V.V. in leg, mild.
Doppler: Mild local reflux in Posterior tibial vein, local and sus
tained 4-second Valsalva reflux in the popliteal vein. Late onset
reflux in GSV, as found with perforator reflux. Normal phasic flow
in common femoral vein.
Phase II.
Duplex scan: Occlusion of SFV to adductor canal.
PFV-popliteal connection, with 2 second reflux
SFV-popliteal collateral, with 4 second reflux
Incompetent greater saphenous vein, with low velocity 4-second
reflux
Popliteal, crural, and short saphenous reflux, low velocity, 4
second duration
Incompetent, 2.0 mm perforators, medial and lateral lower calf,
single
Summary: Post-thrombotic extremity with mixed obstruction and
reflux. Occlusion of entire SFV, and low velocity reflux in all veins.
APG: O.F.-normal at 50%
VFI - 2.72 ml/min
2.10 ml/min with superficial occlusion
VV -75 ml
Ejection Vol - 58 ml Ejection Fraction - 77%
RVF -51%
Summary: Normal outflow and reflux volumes. Calf muscle pump
satisfactory. Elevated RVF
Venous Pressure:
AVP: GSV: sustained high pressure without fall while walking
Dorsal toe vein: Normal fall to 30mm HG, rapid rise (<10 sec)
Arm-foot: Resting: <4 mm. Hg. Difference
Post hyperemia: 7 mm. Hg difference
Summary: Sustained venous hypertension and rapid return to baseline
(Difference between GSV and toe tracings not explained)
Consistent with deep venous obstructive and reflux disease
Summary of Phase II workup and case analysis:
Findings diagnostic of post-thrombotic disease with elements of
reflux and of obstruction shown on duplex. Physiologic confirma
tion of significant obstruction and reflux lacking in APG. Venous
pressure consistent with venous disease, both obstructive and reflux.
Further workup needed to find a way to improve his symptoms since
his present way-of-life was unsatisfactory.
Phase III.
Ascending venogram: Ascending flow preferentially by superficial
veins, even with tourniquet at the ankle. Ankle and upper calf
tourniquets required to force flow into severely distorted tibial,
popliteal, and SFV-PFV veins. Popliteal vein distorted, becoming
obstructed above popliteal space.
Large GSV, main outflow tract from the calf.
The LSV (SSV) ended in a Giacomini vein which ascended to join
the saphenofemoral junction. There was no connection between the
LSV and the popliteal.
Normal CFV-Iliac-IVC.
No significant calf or thigh perforator veins seen.
Descending venogram: Upright examination with Valsalva re
vealed:
Non-visualization of SFV
Reflux in distorted PFV down through PFV-popliteal branch into
popliteal vein, and then reflux down into anterior tibial and muscular
veins. One large lateral branch of the CFV (common femoral vein)
showed a competent valve.
GSV showed slight reflux in thigh only. (Valve leaflets seen in
GSV.)
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CEAP: C2,3,4,5(s); Es; As,p,d; Pr2.3.4,5, 12, 14, 15, 18; o12, 13, 14, 15
Analysis of workup:
Life-style limiting venous claudication, pain, and swelling in an
otherwise healthy and athletic 47 year old male. Healed ulceration
and significant skin changes. The problem was due to post-thrombotic
disease which had virtually wiped out the deep venous return in the
deep veins. Most of the obstruction was in the lower thigh, extend
ing down through the popliteal into the calf veins. Reflux of greater
or less degree was present in all veins except two, and these were the
Giacomini vein and the lateral branch of the PFV. The GSV and the
perforator veins were not of great importance in the process. The
dominant symptoms which limited his lifestyle appeared to be due
to poor emptying of the calf. Outflow from the calf was limited by
deep vein obstruction in the SFV. poor collaterals, and reflux in the
PFV. Outflow channels were the GSV. the Giacomini extension of
the SSV, and possibly the competent lateral branch of the PFV (Fig.
1).
Figure 1
Diagram of pre-operative condition determined by duplex scan and venography. A,
upper end Giacomini vein with competent valve. B, junction of LSV with Giacomini vein
at popliteal level, showing obliteration of branch to popliteal vein. C, incompetent
profunda temoris vein with large communication to poplital vein. D, permanently
occluded superticial femoral vein. E, lateral branch of common femoral vein with
competent valve.
Figure 2
Diagram of surgical procedure. A, upper end of Giacomini vein with competent valve
utilized as outflow for the popliteal vein. B, lower end of Giacomini vein disconnected
from LSV and anastomosed to popliteal vein to serve as popliteal outflow. C, incompe.
tent PFV disconnected from CFV and transposed to the competent lateral branch of the
CFV. D, permanently occluded SFV. E, Competent valve in lateral branch of CFV.
A
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DISCUSSION
DR. O’DONNELL: That was an excellent presentation, and
represents one of the largest experiences with this problem.
DR. GLOVIC’ZKI: Well, this is an extremely complex case, no
question about it, and I may follow a little bit what Mike was
suggesting, try to stay on the conservative side before I would decide
on any type ofdeep vein reconstruction. I ‘in even thinking ofsome
kind ofa May-Husni operation to use the saphenous vein to bypass
the obstruction.
DR. O’DONNELL: Do you think they’re missing something in the
iliac segment?
DR. GLOVICZKI: Icertainly would look very, very carefully into
that venogram. I don’t have large experience repairing deep vein
valve incompetence of the profunda femoris vein, that’s another
option that could be done in this case.
DR. DEPALMA: Tom Wakefieldpointed something out thatMike
Dalsing emphasized too, that this patient may be suffering from
repeated episodes of thrombophlebitis. I would seriously consider
long-term anticoagulation and Heparin or low molecular weight
Heparin therapy with elevation to see if these would improve his
symptoms. If not a surgical intervention can be considered. Dr.
Husni was a friend of mine in Cleveland. I did six of these
operations. None of them worked so I quit. So I don’t see why the
May-Husni procedure would help this man, and if the saphenous
thrombosed he’d lose his outflow tract.
DR. PERRIN: Conservative treatment and anticoagulation. I
have been very disappointed by saphenotibial bypass. I have
performed I would say 20 years ago 25 or something like that, and
the results were not good. May in Austria and Chris in Germany
have the same poor results.
DR. GARCIA -RJNA LDI: Id like to propose to Dr. Dalsing that
maybe the approach of taking the entire circumference of the vein
has been yourproblem. We have approached thisproblem by taking
a inonocusp patch made of the pulmonary arter ofhuman beings.
cryopreserved, and we have implanted this in over 50 cases.
They ye beenfollowedfor up tofive years. We have not had a single
case of thrombosis even though these patients go home on aspirin,
and I would propose that as an alternative to the entire circumfer
ence replacement. There seems to be a mechanism not known to me
that protects this particular patch from thrombosis ifyou leave the
posterior aspect of the host of vein.
DR. RAJU: I think lam notfullv understanding what you are saying.
DR. GARCIA-RINALDI: But I’m not proposing a model. I’m
telling you I’ve done it.
DR. RAJU: I amfamniliar with your earlier work. I urge you to
publish your latest results.
DR. GARC’IA-RINALDI: if you take a monocusp and you place
itproperlv, you will get competence. The problem we’ve seen or the
problem we ‘ic had in some of these patients is the actual sizing of
the prosthesis because we have had to use whatever LifeNet will
send us. However, the bioprosthesis comes as a patch, not as a
pubnonarv artery trunk. So we are implanting a patch, and this we
tested to be totally competent at the time ofsurgery by releasing the
proximal clamp and placing it in the common femoral vein.
DR. DALSING: I really have no specific information how
synthetic graft.s fail. I feel that the problem with cryopreserved
tissue is probab/v some low-grade rejection response. Certainly if
you do not aggressively anticoagulate these patients or if the
anticoagulation levels drop or if the patientfails to take his medica
tion, the allograft willfail. I know, at least in animal models, that
if you place any kind of synthetic in the venous systems that they’ll
fail. So I’d be interested to see your data because I would expect to
see different results.
DR. TRIPATHI: Mv first question is for Dr. Dalsing. There is a
high incidence ofincompetence ofyour crvopreserved vein valve at
six months. I also notice that there is no external supportfor your
vein. Have you tried external support and are the results better with
external support?
DR. DALSING: We have not tried external support. I can tell you
a little bit about what happens to these veins when the)’ fail. It
doesn’t seem to be a dilation problem. They seem tofibrose. So I
thinkputting an external support around them wouldprobably make
little difference.
DR. TRIPA THI: My second question isfor Dr. Raju. It has been
seen that nearly 30 to 50 percent ofall axillary veins are incompe
tent. Do you always use axillary veins for femoral vein valve
transplant or do you lookfor superficialfemoral vein andpopliteal
veins of the contralateral limb whenever there is a duplication?
DR. RAJU: No, I don’t think you should go to the contralateral
limb. You are dealing with a disease which is bilateral in a large
percentage of cases. Incompetent axillary vein can be repaired
before you insert it in large number of cases.
DR. O’DONNELL: Using the external valvuloplasty technique
that Bob has developed, we usually take itfrom the nondominant arm.
DR. TRIPA THI: My last statement is a comment about the iliac
angioplasty. Learning from our techniques of iliac angioplasty,
especially at the aortoiliac junction, wefound that unless you use a
kissing balloon technique you are going to decrease the lumen ofthe
opposite side.
DR. RAJU: Not true in the veins.
DR. TRIPATHI: That’s what I want to know, whether von are
using a kissing balloon technique, and whether you are evaluating
the opposite side common iliac vein after doing the ipsilateral
common iliac angioplas, especially when you are advocating
putting the stent way up into the IVC?
DR. RAJU: We have not looked at the opposite side in every case.
There has been no problem with the opposite side. I don ‘t think the
kissing balloon is necessary in the venous system because oflack of
rigiditi’. It’s not the same thing as in the artery.
DR. HASANIYA: This question is for Dr. Dalsing. Do yj think
that the failure rate could be related to other immune process and
do you think in your experience that immune suppression might help
decrease the failure rate?
DR. DALSING: I can only tell you a little bit about the arterial
system where there seems to be cytotoxic T cells that causes much
ofthe problem. So there has been some suggestion that immunosup
pressive drugs directed to this T cell population may imp rove
results. I have not had any personal experience with this, but I do
believe it is being carefully considered by those involved with
crvopreserved tissues.
DR. THORPE: This case represents, I think, a good example of
how video phlebography, ifyou will, could help us understand tins
patient’s problem because by looking at the still images, I can’t tell
exactly where the stasis is. Is it mostly in the calf or mostly in the
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thigh, or is there any clearance problem through the iliac, as well?
Hopefully, in the future, we’ll advance towards phlebography with
digital imaging. I’d like to ask Dr. Neglen if you’ve used duplex
velocities in thefemoral before and after therapy, particularly after
stent placement, to assess theflow? This might help you determine
whether or not you ‘ye got enough stent opening to remain patent.
DR. NEGLEN: Yes. All the patients have duplex ultrasound
before and aftersurgery. Many ofthem do have decreased augmen
tation and a lack of respiratory changes before which is abolished
by the stenting. However, I think ultrasound is too insensitive a test
to detect slight borderline stenosis. For example, the cases of
hyperplasia were not detected by ultrasound. They were detected by
venogram, and they didn’t have any symptoms whatsoever.
DR. GLOVICZKI: Peter, this is a wondemful series that you
presented, but the indication seems to be differentfrom our conven
tional indications of reconstruction for obstruction. I mean, you
only had 18 percent of the patients who had greater than two
millimeters ofmercury pressure difference at best. That to me looks
like maybe the circulation in most ofthese patients is sufficient and
you did not really have functional obstruction in most of your
patients. So what did you base your indications on?
DR. NEGLEN: Well, as I told you, we’re trying tofind the actual
venous pressures which detect sigrnjficant stenosis. I think the
biggest problem is that in a supine position on an operating or
radiology table, it is difficult to increase the venous flow enough to
detect significant obstruction. It’s a lowflow/low pressure area as
we talked aboutyesterday. The question is when you have collaterals,
does that mean you have compensated the outflow obstruction, or
does it mean that collaterals actually indicate that you have an
ongoing outflow obstruction? So these are the kinds ofquestions we
are trying to resolve. Unfortunately, there is no correlation between
the intraoperativefindings, thepreoperativefindingspressure-wise,
and the postoperative clinical results. Unfortunately, with present
diagnostic methods there arepatients who have normalpressures in
the presence of stenosis, who experience very good results post
stenting.
DR. GLOVICZKI: You had ankle-arm pressure measurements?
Or did you have any type of outflow obstruction on plethysmogra
phy?
DR. NEGLEN: Oh, yes. These patients were fully investigated
with ankle-arm pressures and hyperemia pressures and so on. As I
showed, the pickup rate for the proximal stenosis by reverse pres
sure testing, even if they are severe, is not very high. Even though
we have been proposing the arm/foot hyperemia test to be the best
available test presently, we don’t think it is good in all situations,
and we’re still looking for a better test.
DR. DALSING: Ijust have one question for Peter too. How do
you inject the papaverine?
DR. NEGLEN: Intra-arterially at the level ofthefemoral artery.
DR. OSMAN: Jam one ofthose unfortunate souls who occasion
ally have to see 50 patients on a Tuesday afternoon. I have a
question to Professor Raju. I may have misheard him, but I
understood in this last case that he would have stripped the long
saphenous vein which I thought in this particular patient may have
made things a lot worse. Did I mishear you or is that the case?
DR. RAJU: No, you didn’t misunderstand me. We presented data
yesterday to show that you can do it in similar type of situations
without any clinical mal sequelae and oftentimes with clinical
improvement fthere is sigrnficant reflux. The paper was in Surgery
last year.
SURGICAL MANAGEMENT
DR. KISTNER: We didn’t want to operate on the patient, but the
patient would not leave without having something done. He said,
“My quality of life is so impaired, do whatever you can do. I’m not
leaving here until you do something.” This led to surgery, even
though there were few encouraging findings for a surgical approach.
We did have extensive venography of the pelvis and there was
nothing abnormal in the iliac vein, so proximal obstruction was not
part of the syndrome. We analyzed the case as being severely
obstructed in the thigh, compounded by post-thrombotic reflux.
Please recall that the patient had a Giacomini vein visualized on the
ascending venogram. We disconnected the popliteal termination of
the lesser saphenous and moved it down to a more advantageous soft
spot on the popliteal vein; this converted the Giacomini vein, which
had a valve in it, to an outflow tract for the calf to help the
obstruction. We left the greater saphenous vein intact because it was
a good outflow tract for the leg. The really non-standard thing we
did was to interrupt the profunda femoris vein which was refluxing,
and perform an end-to-side transposition between the PFV and the
lateral femoral branch because this lateral femoral vein provided a
valved outflow for the profunda femoris vein. These procedures
were thought to be low risk. The patient post-op felt improved right
away. He’s now three years post-op. On duplex scan done else
where, both of these reconstructions are patent. I spoke to him on the
phone this weekend because he lives elsewhere. The patient has
returned to hunting. He’s back to full-time work. He discarded his
pump. He continues to use stockings. At least for three years to this
point, he has obtained the result he was seeking.
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